하이로닉 인터내셔널 웹사이트로 이동합니다.
인터내셔널 웹사이트에는 수출용 제품으로 대한민국에서 허가하지 않은 장비 및 서비스 내용을 포함하고 있습니다. 해당 내용은 대한민국의 의료기기 광고 심의, 규제를 받지 않습니다.
It goes to the HIRONIC INTL. website.
The Intrrnation Web Site contains equipment and services that are not authorized by the Republic of Korea These contents are not subject to review and regulation of medical devices in Korea.
하이로닉 US 웹사이트로 이동합니다.
US 웹사이트의 내용은 "FDA"로 부터 허가승인된 품목의 제품 정보에 관한 것으로, 대한민국의 소비자 보호를 위한 국내법 의료기기의 광고 심의, 규제를 받지 않습니다.
It goes to the HIRONIC US website.
The contents of the US web page are about product information of items approved for "FDA". They are not subject to advertising deliberation and regulation of domestic law medical devices for consumer protection in Korea.
하이로닉 EU 웹사이트로 이동합니다.
EU 웹사이트의 내용은 "CE MDD 또는 CE MDR"로 부터 허가승인된 품목의 제품 정보에 관한 것으로, 대한민국의 소비자 보호를 위한 국내법 의료기기의 광고 심의, 규제를 받지 않습니다.
It goes to the HIRONIC EU website.
The contents of the EU(European) web page are about product information of items approved for "CEMDD or CEMDR" in EU countries. They are not subject to advertising deliberation and regulation of domestic law medical devices for consumer protection in Korea.
HIRONIC Inc. (CEO Jinwoo Lee), a leading medical aesthetics device manufacturer, announced the successful completion of its “SILKRO Seminar” held last month in Istanbul, Türkiye, in partnership with its local distributor, Nora Medikal.
The seminar gathered around 80 local dermatologists, including current and potential users of SILKRO, highlighting the device's advanced features and clinical efficacy. The event served as a platform to share real-world clinical experiences and treatment outcomes, drawing strong interest from the attending medical professionals.
Key sessions of the seminar focused on the unique functionalities of SILKRO, treatment protocols using various handpieces, and data-driven clinical outcomes. In particular, a presentation comparing the combined use of the RM and PS handpieces with competitor devices in terms of both technology and design excellence received enthusiastic attention from participants.
Live demonstrations using the microneedling and plasma handpieces simulated real clinical settings, offering hands-on insights into practical device usage and treatment protocols. Detailed discussions on country-specific treatment trends and handpiece combinations provided valuable guidance and sparked engaging dialogue among attendees.
A HIRONIC spokesperson commented, “The local dermatologists expressed high confidence in the safety and effectiveness of our devices. Active interaction between speakers and the audience helped strengthen both brand awareness and trust.”
HIRONIC also shared its strategy to further solidify its presence in Türkiye and across Europe by expanding localized marketing efforts and continuing clinical-driven promotional activities.
